| Dr Thomas Rieter Greenwood, DO | |
|
1806 W Lincoln Ave, Yakima, WA 98902-2473 | |
| (509) 452-4520 | |
| (509) 452-5224 |
| Full Name | Dr Thomas Rieter Greenwood |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 5 Years |
| Location | 1806 W Lincoln Ave, Yakima, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063941656 | NPI | - | NPPES |
| 2135784 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OL60959551 (Washington) | Secondary |
| 207Q00000X | Family Medicine | OP61171137 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Essentia Health St Mary's Medical Center | Duluth, MN | Hospital |
| Essentia Health Duluth | Duluth, MN | Hospital |
| Deer River Healthcare Center | Deer river, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Duluth Clinic Ltd | 2567374283 | 932 |
News Archive
Cyrenaic Pharmaceuticals Inc. a private drug development company focused on the treatment of CNS disorders, today announced Phase IIa clinical results for CYR-101, its novel investigational drug for the treatment of schizophrenia. The results from the study showed that the drug alleviated the symptoms of the disease, including the negative and cognitive symptoms.
OncoGenex Pharmaceuticals, Inc., announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the effectiveness of cancer therapies.
Only about 1% of newly developed drugs are for tropical diseases, such as African sleeping sickness and dengue fever. While patent incentives have driven commercial pharmaceutical companies to make Western health care the envy of the world, the commercial model only works if companies can sell enough patented products to cover their R&D costs and produce profits for shareholders.
Calcium supplements might increase the risk of having a heart attack, and should be "taken with caution," concludes research published in the online issue of the journal Heart.
› Verified 8 days ago
| Entity Name | The Duluth Clinic Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902563638 PECOS PAC ID: 2567374283 Enrollment ID: O20031103000229 |
News Archive
Cyrenaic Pharmaceuticals Inc. a private drug development company focused on the treatment of CNS disorders, today announced Phase IIa clinical results for CYR-101, its novel investigational drug for the treatment of schizophrenia. The results from the study showed that the drug alleviated the symptoms of the disease, including the negative and cognitive symptoms.
OncoGenex Pharmaceuticals, Inc., announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the effectiveness of cancer therapies.
Only about 1% of newly developed drugs are for tropical diseases, such as African sleeping sickness and dengue fever. While patent incentives have driven commercial pharmaceutical companies to make Western health care the envy of the world, the commercial model only works if companies can sell enough patented products to cover their R&D costs and produce profits for shareholders.
Calcium supplements might increase the risk of having a heart attack, and should be "taken with caution," concludes research published in the online issue of the journal Heart.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Rieter Greenwood, DO 501 S 5th Ave, Yakima, WA 98902-3550 Ph: (509) 853-1082 | Dr Thomas Rieter Greenwood, DO 1806 W Lincoln Ave, Yakima, WA 98902-2473 Ph: (509) 452-4520 |
News Archive
Cyrenaic Pharmaceuticals Inc. a private drug development company focused on the treatment of CNS disorders, today announced Phase IIa clinical results for CYR-101, its novel investigational drug for the treatment of schizophrenia. The results from the study showed that the drug alleviated the symptoms of the disease, including the negative and cognitive symptoms.
OncoGenex Pharmaceuticals, Inc., announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the effectiveness of cancer therapies.
Only about 1% of newly developed drugs are for tropical diseases, such as African sleeping sickness and dengue fever. While patent incentives have driven commercial pharmaceutical companies to make Western health care the envy of the world, the commercial model only works if companies can sell enough patented products to cover their R&D costs and produce profits for shareholders.
Calcium supplements might increase the risk of having a heart attack, and should be "taken with caution," concludes research published in the online issue of the journal Heart.
› Verified 8 days ago
Dr. Stephen G Litchfield, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 210 S 11th Ave, Suite 44, Yakima, WA 98902 Phone: 509-248-4586 Fax: 509-576-8857 | |
Dr. Sheau-fang Pan, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1806 W Lincoln Ave, Yakima, WA 98902 Phone: 509-452-4520 Fax: 509-452-5224 | |
Dr. Eve K Barker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1806 W Lincoln Ave, Yakima, WA 98902 Phone: 509-452-4520 Fax: 509-452-5224 | |
Paul E Emmans Jr., D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 402 S 12th Ave, Yakima, WA 98902 Phone: 509-574-6139 Fax: 509-574-6138 | |
Dr. Duane Eugene Teerink, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 311 S 72nd Ave, Yakima, WA 98908 Phone: 509-972-1818 Fax: 509-225-2706 | |
Michael Jach, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 602 E Nob Hill Blvd, Yakima, WA 98901 Phone: 509-248-3334 Fax: 509-453-6144 | |
Dr. Mia-anne Paolucci, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1806 W Lincoln Ave, Yakima, WA 98902 Phone: 509-452-4520 |